Postoperative ComplicationsNCT06816576
The Effect of Emotional Freedom Techniques Application on Patients With Cancer Phobia
A study testing Emotional Freedom Technique in people with Postoperative Complications and Emotion Regulation, run by Bitlis Eren University at 1 site in Turkey (Türkiye).
Trial summary
The aim is to examine the effect of Emotional Freedom Technique on death anxiety in patients with postoperative cancer phobia. The hypotheses of the study are as follows: H0: Emotional Freedom Technique has no effect on postoperative death anxiety in patients with cancer phobia. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Postoperative Complications, Emotion Regulation, Death Anxiety
- What is being tested?
- Emotional Freedom Technique
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 120 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 10 Feb 2025to 10 Oct 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Being over 18 years of age,
- Having had oncological surgery,
- Having no visual or auditory problems,
- Having no psychiatric problems.
Who cannot join
- Not accepting to participate in the study or wanting to leave,
- Being under 18 years of age,
- Having been previously diagnosed with cancer.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Principal Investigator, Assistant Professor Şerafettin OKUTAN, Surgical Nursing, Faculty of Health Sciences, Bitlis Eren University
The aim is to examine the effect of Emotional Freedom Technique on death anxiety in patients with postoperative cancer phobia.
The hypotheses of the study are as follows:
H0: Emotional Freedom Technique has no effect on postoperative death anxiety in patients with cancer phobia.
H1: Emotional Freedom Technique has a positive effect on postoperative death anxiety in patients with cancer phobia.
Read the detailed description
Intervention Group
After coming to the clinic after surgery and after their condition was stable, the patients were given the patient introduction form, subjective discomfort unit, cancer anxiety scale and death anxiety scale as a pre-test. The researchers provided Emotional Freedom Technique (EFT) training to the patients and asked them to apply Emotional Freedom Technique. After an average of 3 days, the subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a post-test.
Control Group
After coming to the clinic after surgery and after their condition was stable, the patient introduction form, subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a pre-test. No intervention was made to the control group patients outside the clinical protocol. After an average of 3 days, the subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a post-test.
- Being tested
- Emotional Freedom Technique
- Keywords
- Death Anxiety, postoperative, Emotional Freedom Technique, cancer phobia
- Medical subject headings
- Postoperative Complications, Emotional Regulation, Necrophobia, Pathophobia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Emotional Freedom TechniqueOther
Emotional Freedom Technique application; It is an application that works on cognitive and energetic levels. Emotional Freedom Technique Application Instructions
- Determination of Subjective Units of Disturbance (SUD)
- Preparation or setup
- Application of appropriate acupuncture points in order
- 9-Gamut: An application that allows the two hemispheres of the brain to be stimulated simultaneously
- Application of appropriate acupuncture points in order again
- Control of the differentiation in the level of discomfort with Subjective Units of Disturbance again
| Study group | Role | What they receive |
|---|---|---|
| Intervention Group | Experimental | After coming to the clinic after surgery and after their condition was stable, the patients were given the patient introduction form, subjective discomfort unit, cancer anxiety scale and death anxiety scale as a pre-test. The researchers provided EFT training to the patients and asked them to apply EFT. After an average of 3 days, the subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a post-test. Receives: Other: Emotional Freedom Technique |
| Control Group | No intervention | After coming to the clinic after surgery and after their condition was stable, the patient introduction form, subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a pre-test. No intervention was made to the control group patients outside the clinical protocol. After an average of 3 days, the subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a post-test. |
What is being measured
The primary outcome is the main question the study is designed to answer.
death anxiety
Death Anxiety Scale:
The scale developed by Templer was translated into Turkish by Sarıkaya and Baloğlu. The scale consists of 20 items. High scores indicate high death anxiety.
Measured: After coming to the clinic after surgery and their condition becoming stable, the death anxiety scale was applied to the patients as a pre-test. Three days later, the death anxiety scale was applied as a post-test.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Feb 2025
- Study start10 Feb 2025
- Primary completion28 Sep 2025
- Study completion10 Oct 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Postoperative ComplicationsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Crossover
- Model description
- It will be conducted as a randomized controlled experimental study in a pre-testpost- test control group experimental model.
- Masking
- None (open label)
- Enrolment
- 120 participants (actual)
Sponsor and investigators
- Lead sponsor
- Bitlis Eren University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Serafettin Okutan, Bitlis Eren University
- Investigators
- Şerafettin OKUTAN, Dr., Principal investigator, Bitlis Eren University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06816576
- Sponsor's protocol ID
- okutan1
- Status last verified
- Dec 2025
- First submitted
- 2 Feb 2025
- Last updated
- 5 Jan 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Principal Investigator, Assistant Professor Şerafettin OKUTAN, Surgical Nursing, Faculty of Health Sciences, Bitlis Eren University
- ClinicalTrials.gov ID
- NCT06816576
- Acronym / sponsor ID
- okutan1
- Keywords
- Death Anxiety, postoperative, Emotional Freedom Technique, cancer phobia
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 120 participants (actual)
- Lead sponsor
- Bitlis Eren UniversityUniversity, hospital or other
- Study start
- 10 Feb 2025 (actual)
- Primary completion
- 28 Sep 2025 (actual)
- Study completion
- 10 Oct 2025 (actual)
- First posted
- 10 Feb 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim is to examine the effect of Emotional Freedom Technique on death anxiety in patients with postoperative cancer phobia.
The hypotheses of the study are as follows:
H0: Emotional Freedom Technique has no effect on postoperative death anxiety in patients with cancer phobia.
H1: Emotional Freedom Technique has a positive effect on postoperative death anxiety in patients with cancer phobia.
Detailed description
Intervention Group
After coming to the clinic after surgery and after their condition was stable, the patients were given the patient introduction form, subjective discomfort unit, cancer anxiety scale and death anxiety scale as a pre-test. The researchers provided Emotional Freedom Technique (EFT) training to the patients and asked them to apply Emotional Freedom Technique. After an average of 3 days, the subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a post-test.
Control Group
After coming to the clinic after surgery and after their condition was stable, the patient introduction form, subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a pre-test. No intervention was made to the control group patients outside the clinical protocol. After an average of 3 days, the subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a post-test.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- It will be conducted as a randomized controlled experimental study in a pre-testpost- test control group experimental model.
| Arm | Type | Receives |
|---|---|---|
| Intervention Group | Experimental | Other: Emotional Freedom TechniqueAfter coming to the clinic after surgery and after their condition was stable, the patients were given the patient introduction form, subjective discomfort unit, cancer anxiety scale and death anxiety scale as a pre-test. The researchers provided EFT training to the patients and asked them to apply EFT. After an average of 3 days, the subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a post-test. |
| Control Group | No intervention | –After coming to the clinic after surgery and after their condition was stable, the patient introduction form, subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a pre-test. No intervention was made to the control group patients outside the clinical protocol. After an average of 3 days, the subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a post-test. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Being over 18 years of age,
- Having had oncological surgery,
- Having no visual or auditory problems,
- Having no psychiatric problems.
Key exclusion criteria (3 listed)
- Not accepting to participate in the study or wanting to leave,
- Being under 18 years of age,
- Having been previously diagnosed with cancer.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Emotional Freedom TechniqueEmotional Freedom Technique application; It is an application that works on cognitive and energetic levels. Emotional Freedom Technique Application Instructions 1. Determination of Subjective Units of Disturbance (SUD) 2. Preparation or setup 3. Application of appropriate acupuncture points in order 4. 9-Gamut: An application that allows the two hemispheres of the brain to be stimulated simultaneously 5. Application of appropriate acupuncture points in order again 6. Control of the differentiation in the level of discomfort with Subjective Units of Disturbance again | Other | Intervention Group |
Primary outcome
death anxiety
Time frame: After coming to the clinic after surgery and their condition becoming stable, the death anxiety scale was applied to the patients as a pre-test. Three days later, the death anxiety scale was applied as a post-test.
Death Anxiety Scale: The scale developed by Templer was translated into Turkish by Sarıkaya and Baloğlu. The scale consists of 20 items. High scores indicate high death anxiety.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Jan 2026.
Related trials for Postoperative Complications
Recruiting
Endo-SPONGE for Treatment of Anastomotic or Hartmann's Stump Leakages in Lower Pelvic Area
Anastomotic Leaks, Hartmanns Stump Leakage
Not yet recruitingObservational study
Comparison of Reliability, Time Cost, and Participant Comfort of Lymphedema Assessments in Upper Extremity
Lymphedema, Upper Extremity Lymphedema
RecruitingPhase 4
ESP Blocks for Posterior Spinal Fusion
Postoperative Pain
Not yet recruiting
Bispectral Index-Guided Propofol Sedation During Endoscopic Retrograde Cholangiopancreatography
Deep Sedation, Endoscopic Retrograde Cholangiopancreatography
Not yet recruitingObservational study
Systematic Intraoperative Cell Salvage in On-Pump Cardiac Surgery Within a Mature Patient Blood Management Programme
Cardiac Surgical Procedures, Blood Transfusion
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Şerafettin OKUTAN, Dr. principal investigator
Bitlis Eren University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Emotional Freedom Technique in people with Postoperative Complications and Emotion Regulation, run by Bitlis Eren University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
death anxiety (time frame: After coming to the clinic after surgery and their condition becoming stable, the death anxiety scale was applied to the patients as a pre-test. Three days later, the death anxiety scale was applied as a post-test.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jan 2026.